Leukemia and Lymphoma Program
The Leukemia and Lymphoma Program at Children’s Hospital Los Angeles aims to provide the highest-quality, family-centered care, which is tailored to meet each patient’s needs. The team of physicians, nurse practitioners, care managers, and social workers work closely with other sub-specialties to take care of children with complex medical problems in addition to their cancer. Our extensive clinical experience and expertise in treatment, monitoring, and supportive care offers children the most advanced therapy options.
The Leukemia and Lymphoma team is searching for more effective, less harmful treatments for children and adolescents battling leukemia and lymphoma. Many of our physicians also serve on committees and various Children’s Oncology Group (COG) studies. The team of providers is leading the development of new treatment approaches designed to kill leukemia cells while sparing normal tissues. This includes conducting bench-to-bedside collaborative studies with laboratory investigators and leading international clinical trials of innovative immune-based and cellular therapies. This means that your child will have access to advanced treatments and the chance to participate in lifesaving clinical trials.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Chronic myeloid leukemia
- Juvenile myelomonocytic leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Other rare leukemias and lymphomas
Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
TACL is a collaborative academic research consortium with 36 member sites from all over the world headquartered at Children’s Hospital Los Angeles. Through cutting-edge research and clinical trials, survival rates for children with leukemia have improved dramatically over the past 50 years, yet leukemia remains a leading cause of pediatric death. TACL is dedicated to saving and improving kids’ lives with various, novel treatment options for relapsed leukemia and lymphoma.
For more information on recently competed and ongoing TACL studies, please click here.
The Leukemia and Lymphoma Program at CHLA is a member of multiple national and international consortia involved in conducting innovative clinical trials for children. Our program offers multiple phase I, II and III clinic trials in new agents, cellular and immunotherapy and an innovative program in stem cell transplantation.
Please click here to view our updated portfolio of clinical trials available at CHLA.